The Ministry of Health has issued permission to test an anti-Covid drug from Pfizer
The Ministry of Health issued permission to conduct clinical trials of a drug for the treatment of COVID-19, produced by the American Pfizer, in Russia. According to studies, it reduces the risk of hospitalization and death of patients with coronavirus by almost 90%. The study began on November 12, and ended on March 14, 2023. The tests will be attended by 90 people in 8 regions of the country: in Moscow, St. Petersburg, Barnaul, Kirovsk, Smolensk, Yekaterinburg, Pyatigorsk and Krasnoyarsk.